A. Langlois

发表

Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein

M. Malim, B. Cullen, J. Hauber, 1988, Nature.

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

A J Langlois, B. Haynes, D. Bolognesi, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain.

J. Morris, F. Wong-Staal, T. Matthews, 1991, AIDS research and human retroviruses.

HIV-1 neutralizing antibody and approaches to the envelope diversity problem.

S. Buttò, D. Bolognesi, T. Matthews, 1991, Advances in experimental medicine and biology.

Antibodies from human immunodeficiency virus-infected individuals bind to a short amino acid sequence that elicits neutralizing antibodies in animals.

T. Matthews, W. Kenealy, S. Petteway, 1989, AIDS research and human retroviruses.

CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALS

D. Tyler, D. Durack, D. Bolognesi, 1988, The Lancet.

Limited Breadth of the Protective Immunity Elicited by Simian Immunodeficiency Virus SIVmne gp160 Vaccines in a Combination Immunization Regimen

D. Montefiori, J. Overbaugh, B. Richardson, 1999, Journal of Virology.

Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys.

B. Haynes, R. Scearce, D. Bolognesi, 1990, Journal of immunology.

Ribonucleic acid components of BAI strain A (myeloblastosis) avian tumor virus.

D. Bolognesi, A. Langlois, D. Beard, 1967, Cancer research.

Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein

B. Haynes, L. Arthur, R. Scearce, 1993, The Journal of experimental medicine.

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

G. Barber, Shiu-Lok Hu, L. Kuller, 1992, Science.

The ability of certain SIV vaccines to provoke reactions against normal cells.

D. Bolognesi, T. Matthews, K. Weinhold, 1992, Science.

Influence of toyocamycin on avian leukemia myeloblasts: cell growth, ultrastructure, RNA synthesis, and elaboration of BAI strain A virus.

A. Langlois, R. A. Bonar, J. W. Beard, 1970, Cancer research.

Prospects for the immunological management of lethal tumors.

J. Iglehart, D. Bolognesi, T. Matthews, 1983, Cancer investigation.

Ultrastructural alterations in avian leukemia myeloblasts exposed to actinomycin D in vitro.

U. Heine, A. Langlois, J. W. Beard, 1966, Cancer research.

Prospects for development of a vaccine against HIV-related disorders

H. Lyerly, D. Bolognesi, T. Matthews, 1987 .

Prospects for development of a vaccine against HTLV-III-related disorders.

H. Lyerly, R. Gallo, D. Bolognesi, 1987, AIDS research and human retroviruses.

Restricted neutralization of divergent HTLV-III/LAV isolates by antibodies to the major envelope glycoprotein.

R. Gallo, D. Bolognesi, T. Matthews, 1987, Haematology and blood transfusion.

Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus.

D. Bolognesi, T. Matthews, K. Weinhold, 1992, AIDS research and human retroviruses.

Lack of enhancing effect of human anti-human immunodeficiency virus type 1 (HIV-1) antibody on HIV-1 infection of human blood monocytes and peritoneal macrophages

J. Bartlett, D. Bolognesi, T. Matthews, 1991, Journal of virology.

Isolation of a transplantable cell line induced by the MC29 avian leukosis virus.

D. Bolognesi, K. Lapis, R. Ishizaki, 1974, Cancer research.

Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.

H. Lyerly, D. Bolognesi, T. Matthews, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition by toyocamycin of RNA synthesis in mammalian cells and in normal and avian tumor virus-infected chick embryo cells.

A. Langlois, R. A. Bonar, J. W. Beard, 1970, Biochimica et biophysica acta.

Influence of toyocamycin on RNA synthesis in chick embryo cells noninfected and infected with strain MC29 avian leukosis virus.

A. Langlois, J. Říman, R. A. Bonar, 1969, Cancer research.

Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies.

S. Zolla-Pazner, M. Gorny, D. Tyler, 1990, Journal of immunology.

Response of bone marrow to MC29 avian leukosis virus in vitro.

U. Heine, D. Bolognesi, A. Langlois, 1969, Cancer research.

Using Peptides and Peptide Sera Toward Studying the Principal Neutralization Determination of HIV

T. Matthews, J. Rusche, G. Larosa, 1992 .

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120

L. Arthur, J. Bess, R. Gallo, 1989, Journal of virology.

Detection of HIV-1 neutralizing antibodies by a simple, rapid, colorimetric assay.

M. Hershfield, D. Bolognesi, T. Matthews, 1988, AIDS research and human retroviruses.

Interaction between thehumanT-cell lymphotropic virus type"'B envelope glycoprotein gpl20andthesurface antigen CD4: Roleofcarbohydrate inbinding andcell fusion

D. Bolognesi, T. Matthews, K. Weinhold, 1987 .

3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase

K. Weinhold, C. Richards, T. Spector, 1987, Antimicrobial Agents and Chemotherapy.

Commercially available surgical gowns do not prevent penetration by HIV-1

D. Tyler, H. Lyerly, A. Langlois, 1990 .

avian leukosis virus

U. Heine, A. Langlois, J. Říman, 2022, CABI Compendium.

Isolation of two subgroup-specific leukemogenic viruses from standard avian myeloblastosis virus

D. Bolognesi, R. Ishizaki, A. Langlois, 1975, Journal of virology.

Refinement of the Avian Oncornavirus-Induced Primary Rat Brain Tumor Model for Therapeutic Screening

D. Bigner, J. Swenberg, J. Frey, 1975 .

Virus-infected avian cell lines established in vitro.

D. Bolognesi, R. Ishizaki, A. Langlois, 1976, Cancer research.

Isolation of a non-focus-forming agent from strain MC29 avian leukosis virus.

A. Langlois, R. Fritz, D. Beard, 1971, Cancer research.

Strain MC29, an avian leukosis virus of unique properties.

A. Langlois, D. Beard, J. W. Beard, 1970, Bibliotheca haematologica.

Mesotheliomas of peritoneum, epicardium, and pericardium induced by strain MC29 avian leukosis virus.

A. Langlois, D. Beard, J. W. Beard, 1970, Cancer research.

HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope.

A J Langlois, J. Ghrayeb, M. Robert-Guroff, 1986, Science.

Component of Strain MC29 Avian Leukosis Virus with the Property of Defectiveness

R. Ishizaki, A. Langlois, J. W. Beard, 1971, Journal of virology.

Reaction of Chick Embryo Cells Infected with Leukosis Strain MC29 Virus with Fluorescein-Labeled Antibody

A. Langlois, R. Fritz, J. W. Beard, 1969, Journal of virology.

Converted-Cell Focus Formation in Culture by Strain MC29 Avian Leukosis Virus.∗

A. Langlois, J. W. Beard, 1967 .

Effects of Actinomycin D on Avian Myeloblast and BAI Strain A Virus RNA Synthesis in Vitro1

A. Langlois, R. A. Bonar, J. W. Beard, 2006 .

Effects of Actinomycin D on Avian Myeloblast and BAI Strain A Virus RNA Synthesis in Vitro 1

P. R. Rao, A. Langlois, R. A. Bonar, 2006 .

Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells.

M. Robert-Guroff, H. Lyerly, R. Gallo, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Polypeptides of mammalian oncornaviruses. IV. Structural components of murine leukemia virus released as soluble antigens in cell culture.

D. Bolognesi, A. Langlois, W. Schäfer, 1975, Virology.

Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors

T. Matthews, K. Weinhold, C. Perno, 1991 .

Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors.

T. Matthews, K. Weinhold, C. Perno, 1991, Blood.

Morphological and biochemical properties of a new human breast cancer cell line.

J. Iglehart, S. Wells, D. Bolognesi, 1979, Cancer Research.

Barrier protection against the human immunodeficiency virus.

D. Tyler, H. Lyerly, A. Langlois, 1989, Current surgery.

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.

L. Arthur, R. Gallo, D. Lynn, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4

M. Skinner, D. Bolognesi, T. Matthews, 1988, Journal of virology.

Singularity of oncogenic activity of strain MC29 avian leukosis viruses.

A. Langlois, E. Hillman, D. Beard, 1970, Archiv fur Geschwulstforschung.

Strain MC29 avian leukosis virus: immunologic relationships to other avian tumor viruses.

A. Langlois, R. Fritz, D. Beard, 1968, Journal of immunology.

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.

A J Langlois, L. Eckler, D. Bolognesi, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.

A J Langlois, H. Lyerly, D. Bolognesi, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.

H. Lyerly, T. Matthews, K. Weinhold, 1987, AIDS research and human retroviruses.

The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type 1.

R. Desrosiers, R. Meloen, J. Langedijk, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Vaccine protection of rhesus macaques against simian immunodeficiency virus infection.

P. Luciw, R. Donovan, J. Yee, 1990, AIDS research and human retroviruses.

A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope.

R. Snyderman, B. Safai, D. Bolognesi, 1987, Proceedings of the National Academy of Sciences of the United States of America.

B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus

J. Nelson, M. Oldstone, J. Gnann, 1988, Journal of virology.

Massive direct conversion of chick embryo cells by strain MC29 avian leukosis virus

S. Sankaran, A. Langlois, J. W. Beard, 1967, Journal of virology.

Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.

R. Gallo, D. Bolognesi, T. Matthews, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.

L. Arthur, T. Copeland, D. Bolognesi, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1

M. Champe, G. Nakamura, J. Mercer, 1992, Journal of virology.

Conversion of an Intmunogenic Human Immunodeficiency Virus ( HIV ) Envelope Synthetic Peptide to a Tolerogen in Chimpanzees by the Fusogenic Domain of HIV g l ~ l Envelope Protein

B. Haynes, L. Arthur, R. Scearce, 2003 .

Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells.

D. Bolognesi, T. Matthews, K. Weinhold, 1985, Journal of the National Cancer Institute.

Immunologic control of a retrovirus-associated murine adenocarcinoma. VII. Tumor cell destruction by macrophages and IgG2A.

D. Bolognesi, T. Matthews, K. Weinhold, 1985, Journal of the National Cancer Institute.

Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes.

J. Berzofsky, B. Haynes, R. Scearce, 1989, Journal of immunology.

A formalin-fixed whole SIV vaccine induces protective responses that are cross-protective and durable.

O. Narayan, M. Gardner, M. Murphey-Corb, 1992, AIDS research and human retroviruses.

Role of Immune Responses against the Envelope and the Core Antigens of Simian Immunodeficiency Virus SIVmne in Protection against Homologous Cloned and Uncloned Virus Challenge in Macaques

D. Montefiori, B. Richardson, Shiu-Lok Hu, 1999, Journal of Virology.

Neutralizing Antibodies in Sera from Macaques Immunized with Attenuated Simian Immunodeficiency Virus

D. Montefiori, R. Desrosiers, D. Littman, 1998, Journal of Virology.

Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection.

R. Benveniste, W. Morton, A. Langlois, 1996, Immunology letters.

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.

J. Robinson, A. Profy, K. Weinhold, 1990, Proceedings of the National Academy of Sciences of the United States of America.

The initial nucleotide sequence of DNA transcribed from avian myeloblastosis virus 70 S RNA by RNA-dependent DNA polymerase.

D. Bolognesi, J. Eiden, A. Langlois, 1975, Virology.

Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160.

G. Barber, R. Benveniste, W. Morton, 1993, Journal of medical primatology.

Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.

R. Benveniste, W. Morton, A. Langlois, 1992, Journal of medical primatology.

Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection.

W. Morton, A. Langlois, S. Hu, 1992, AIDS research and human retroviruses.

Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein.

H. Lyerly, M. Skinner, T. Matthews, 1988, AIDS research and human retroviruses.

Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.

D. Bolognesi, T. Matthews, H. Thiel, 1981, Journal of immunology.

Normal chicken cells (chf-) express a surface antigen which cross-reacts with determinants of the major envelope glycoprotein (gp85) of avian myeloblastosis virus.

R. Montelaro, T. Denny, R. Ishizaki, 1978, Virology.

The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope.

D. Montefiori, H. Staats, T. Palker, 1996, Virology.

BAI Strain A Avian (Myeloblastosis) Leukosis Virus from Myeloblast Tissue Culture.∗

D. Bolognesi, P. R. Rao, A. Langlois, 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

In vitro assays for detecting neutralizing and fusion-inhibiting antibodies to SIVMAC251.

D. Bolognesi, T. Matthews, K. Weinhold, 1991, AIDS research and human retroviruses.

Effects of actinomycin D on avian myeloblast and BAI strain A virus RNA synthesis in vitro.

P. R. Rao, A. Langlois, R. A. Bonar, 1966, Cancer research.

Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.

B. Haynes, M. A. Moody, R. Scearce, 1993, Journal of immunology.

In Vitro Chick Embryo Cell Response to Strain MC29 Avian Leukosis Virus

D. Bolognesi, A. Langlois, R. A. Bonar, 1968, Journal of virology.

Transmission of avian myeloblastosis by BAI strain A virus ribonucleic acid.

R. Ishizaki, A. Langlois, D. Beard, 1971, Journal of the National Cancer Institute.